Market Research Logo

Sutro Biopharma, Inc. - Product Pipeline Review - 2016

Sutro Biopharma, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Sutro Biopharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sutro Biopharma, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sutro Biopharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Sutro Biopharma, Inc.
The report provides overview of Sutro Biopharma, Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Sutro Biopharma, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Sutro Biopharma, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Sutro Biopharma, Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Sutro Biopharma, Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Sutro Biopharma, Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Sutro Biopharma, Inc. Snapshot
Sutro Biopharma, Inc. Overview
Key Information
Key Facts
Sutro Biopharma, Inc. - Research and Development Overview
Key Therapeutic Areas
Sutro Biopharma, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Sutro Biopharma, Inc. - Pipeline Products Glance
Sutro Biopharma, Inc. - Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Sutro Biopharma, Inc. - Drug Profiles
Monoclonal Antibodies for Cancer
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugate for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugates 1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugates 2 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody for Cancer
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Antagonize CTLA4 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit LAG3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit PD-1 for Cancer
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit PD-L1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit TIM3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Target CD3 for Neuroblastoma
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Target GD2 for Melanoma
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Target GD2 for Neuroblastoma
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Target GD2 for Osteosarcoma
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Sutro Biopharma, Inc. - Pipeline Analysis
Sutro Biopharma, Inc. - Pipeline Products by Target
Sutro Biopharma, Inc. - Pipeline Products by Molecule Type
Sutro Biopharma, Inc. - Pipeline Products by Mechanism of Action
Sutro Biopharma, Inc. - Recent Pipeline Updates
Sutro Biopharma, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sutro Biopharma, Inc., Key Information
Sutro Biopharma, Inc., Key Facts
Sutro Biopharma, Inc. - Pipeline by Indication, 2016
Sutro Biopharma, Inc. - Pipeline by Stage of Development, 2016
Sutro Biopharma, Inc. - Monotherapy Products in Pipeline, 2016
Sutro Biopharma, Inc. - Discovery, 2016
Sutro Biopharma, Inc. - Pipeline by Target, 2016
Sutro Biopharma, Inc. - Pipeline by Molecule Type, 2016
Sutro Biopharma, Inc. - Pipeline Products by Mechanism of Action, 2016
Sutro Biopharma, Inc. - Recent Pipeline Updates, 2016
Sutro Biopharma, Inc., Other Locations
List of Figures
Sutro Biopharma, Inc. - Pipeline by Indication, 2016
Sutro Biopharma, Inc. - Pipeline by Target, 2016
Sutro Biopharma, Inc. - Pipeline by Molecule Type, 2016
Sutro Biopharma, Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report